Integrated measures for prevention of invasive Candida infections in preterm infants in a Chinese neonatal intensive care unit

Published:September 24, 2015DOI:


      The increasing incidence of invasive Candida infections (ICIs) in preterm infants in the neonatal intensive care unit (NICU) of Xinhua Hospital aroused our concern. We undertook a retrospective study to evaluate the efficacy of different preventive measures for ICI in preterm infants.


      Preterm infants with gestational age (GA) <33 weeks admitted between 2010 and 2013 were divided into 3 groups according to the preventive measures applied in different periods: the control group (CG), fluconazole group (FG), and integrated measures group (IMG). We analyzed the incidence of ICI and distribution of fungal pathogens in these 3 groups, and also evaluated the efficiency of various measures in preventing ICIs in preterm infants.


      The study sample comprised 261 preterm infants born at <33 weeks GA, including 94 in the CG, 99 in the FG, and 68 in the IMG. The differences among the groups were not significant at baseline. ICI developed in 41 of the 261 infants (15.7%). The incidence of ICI varied significantly among the groups: 22.3% in the CG (21/94), 18.2% in the FG (18/99), and only 2.9% in the IMG (2/68) (P = .003). ICI was less frequent in the IMG compared with the CG (P <.001) and the FG (P = .003).


      The integrated measures approach is meaningful for the prevention of ICIs in preterm infants in NICUs with many patients but inadequate medical resources in some developing countries.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Chapman R.L.
        Prevention and treatment of Candida infections in neonates.
        Semin Perinatol. 2007; 31: 39-46
        • Makhoul I.R.
        • Kassis I.
        • Smolkin T.
        • Tamir A.
        • Sujov P.
        Review of 49 neonates with acquired fungal sepsis: further characterization.
        Pediatrics. 2001; 107: 61-66
        • Bertini G.
        • Perugi S.
        • Dani C.
        • Filippi L.
        • Pratesi S.
        • Rubaltelli F.F.
        Fluconazole prophylaxis prevents invasive fungal infection in high-risk, very low birth weight infants.
        J Pediatr. 2005; 147: 162-165
        • Kaufman D.
        • Boyle R.
        • Hazen K.C.
        • Patrie J.T.
        • Robinson M.
        • Donowitz L.G.
        Fluconazole prophylaxis against fungal colonization and infection in preterm infants.
        N Engl J Med. 2001; 345: 1660-1666
        • Healy C.M.
        • Baker C.J.
        • Zaccaria E.
        • Campbell J.R.
        Impact of fluconazole prophylaxis on incidence and outcome of invasive candidiasis in a neonatal intensive care unit.
        J Pediatr. 2005; 147: 166-171
        • Uko S.
        • Soghier L.M.
        • Vega M.
        • Marsh J.
        • Reinersman G.T.
        • Herring L.
        • et al.
        Targeted short-term fluconazole prophylaxis among very low birth weight and extremely low birth weight infants.
        Pediatrics. 2006; 117: 1243-1252
        • Kossoff E.H.
        • Buescher E.S.
        • Karlowicz M.G.
        Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases.
        Pediatr Infect Dis J. 1998; 17: 504-508
        • Saiman L.
        • Ludington E.
        • Pfaller M.
        • Rangel-Frausto S.
        • Wiblin R.T.
        • Dawson J.
        • et al.
        Risk factors for candidemia in neonatal intensive care unit patients: the National Epidemiology of Mycosis Survey study group.
        Pediatr Infect Dis J. 2000; 19: 319-324
        • Stoll B.J.
        • Hansen N.
        • Fanaroff A.A.
        • Wright L.L.
        • Carlo W.A.
        • Ehrenkranz R.A.
        • et al.
        Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network.
        Pediatrics. 2002; 110: 285-291
        • Manzoni P.
        • Arisio R.
        • Mostert M.
        • Leonessa M.
        • Farina D.
        • Latino M.A.
        • et al.
        Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: a single-center, 6-year, retrospective cohort study.
        Pediatrics. 2006; 117: e22-e32
        • Manzoni P.
        • Leonessa M.
        • Galletto P.
        • Latino M.A.
        • Arisio R.
        • Maule M.
        • et al.
        Routine use of fluconazole prophylaxis in a neonatal intensive care unit does not select natively fluconazole-resistant Candida subspecies.
        Pediatr Infect Dis J. 2008; 27: 731-737
        • Benjamin Jr., D.K.
        • Stoll B.J.
        • Fanaroff A.A.
        • McDonald S.A.
        • Oh W.
        • Higgins R.D.
        • et al.
        Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.
        Pediatrics. 2006; 117: 84-92
        • Kaufman D.A.
        • Gurka M.J.
        • Hazen K.C.
        • Boyle R.
        • Robinson M.
        • Grossman L.B.
        Patterns of fungal colonization in preterm infants weighing less than 1000 grams at birth.
        Pediatr Infect Dis J. 2006; 25: 733-737
        • Brecht M.
        • Clerihew L.
        • McGuire W.
        Prevention and treatment of invasive fungal infection in very low birth weight infants.
        Arch Dis Child Fetal Neonatal Ed. 2009; 94: F65-F69
        • Roilides E.
        Invasive candidiasis in neonates and children.
        Early Hum Dev. 2011; 87: S75-S76
        • Yu Y.
        • Du L.
        • Yuan T.
        • Zheng J.
        • Chen A.
        • Chen L.
        • et al.
        Risk factors and clinical analysis for invasive fungal infection in neonatal intensive care unit patients.
        Am J Perinatol. 2013; 30: 589-594
        • Adams-Chapman I.
        • Stoll B.J.
        Prevention of nosocomial infections in the neonatal intensive care unit.
        Curr Opin Pediatr. 2002; 14: 157-164
        • Whitby M.
        • McLaws M.L.
        • Slater K.
        • Tong E.
        • Johnson B.
        Three successful interventions in health care workers that improve compliance with hand hygiene: is sustained replication possible.
        Am J Infect Control. 2008; 36: 349-355
        • Ascioglu S.
        • Rex J.H.
        • de Pauw B.
        • Bennett J.E.
        • Bille J.
        • Crokaert F.
        • et al.
        Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.
        Clin Infect Dis. 2002; 34: 7-14
        • Society of Critical Care Medicine, Chinese Medical Association
        Guidelines on diagnosis and treatment of invasive fungal infection in critically ill patients.
        Chin J Pediatr. 2007; 46: 960-966
        • Aziz M.
        • Patel A.L.
        • Losavio J.
        • Iyengar A.
        • Berven M.
        • Schloemer N.
        • et al.
        Efficacy of fluconazole prophylaxis for prevention of invasive fungal infection in extremely low birth weight infants.
        Pediatr Infect Dis J. 2010; 29: 352-356
        • Kaufman D.
        • Boyle R.
        • Hazen K.C.
        • Patrie J.T.
        • Robinson M.
        • Grossman L.B.
        Twice- weekly fluconazole prophylaxis for prevention of invasive Candida infection in high-risk infants of <1000 grams birth weight.
        J Pediatr. 2005; 147: 172-179
        • McCrossan B.A.
        • McHenry E.
        • O'Neill F.
        • Ong G.
        • Sweet D.G.
        Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.
        Arch Dis Child Fetal Neonatal Ed. 2007; 92: F454-F458
        • Hope W.W.
        • Castagnola E.
        • Groll A.H.
        • Roilides E.
        • Akova M.
        • Arendrup M.C.
        • et al.
        • ESCMID Fungal Infection Study Group
        ESCMID guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp.
        Clin Microbiol Infect. 2012; 18: 38-52
        • Manzoni P.
        • Mostert M.
        • Jacqz-Aigrain E.
        • Farina D.
        The use of fluconazole in neonatal intensive care units.
        Arch Dis Child. 2009; 94: 983-987
        • Manzoni P.
        • Jacqz-Aigrain E.
        • Rizzollo S.
        • Franco C.
        • Stronati M.
        • Mostert M.
        • et al.
        Antifungal prophylaxis in neonates.
        Early Hum Dev. 2011; 87: S59-S60
        • Clerihew L.
        • Austin N.
        • McGuire W.
        Systemic antifungal prophylaxis for very low birthweight infants: a systematic review.
        Arch Dis Child Fetal Neonatal Ed. 2008; 93: F198-F200
        • Austin N.C.
        • Darlow B.
        Prophylactic oral antifungal agents to prevent systemic Candida infection in preterm infants.
        Cochrane Database Syst Rev. 2004; : CD003478
        • Kaufman D.
        Strategies for prevention of neonatal invasive candidiasis.
        Semin Perinatol. 2003; 27: 414-424
        • Kaufman D.A.
        • Cuff A.L.
        • Wamstad J.B.
        • Boyle R.
        • Gurka M.J.
        • Grossman L.B.
        • et al.
        Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age.
        J Pediatr. 2011; 158: 759-765
        • Healy C.M.
        • Campbell J.R.
        • Zaccaria E.
        • Baker C.J.
        Fluconazole prophylaxis in extremely low birth weight neonates reduces invasive candidiasis mortality rates without emergence of fluconazole-resistant Candida species.
        Pediatrics. 2008; 121: 703-710
        • Kaufman D.A.
        Fluconazole prophylaxis: can we eliminate invasive Candida infections in the neonatal ICU?.
        Curr Opin Pediatr. 2008; 20: 332-340
        • Manzoni P.
        • Stolfi I.
        • Pugni L.
        • Decembrino L.
        • Magnani C.
        • Vetrano G.
        • et al.
        A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.
        N Engl J Med. 2007; 356: 2483-2495
        • Bao Y.
        • Du L.Z.
        • Shi L.P.
        • Cheng X.Y.
        Clinical significance of oral fluconazole prophylaxis against invasive fungal infection in preterm neonates with peripherally inserted central catheters.
        Chin J Pediatr. 2010; 48 (in Chinese): 510-513
        • Chen H.Q.
        • Yang W.Q.
        • Yang C.Y.
        • et al.
        Fluconazole prophylaxis for fungal infection in high risk preterm infants receiving broad-spectrum antibiotics over 10 days.
        Chin J Perinat Med. 2010; 13: 286-289
        • López Sastre J.B.
        • Coto Cotallo G.D.
        • Fernández Colomer B.
        • Grupo de Hospitales Castrillo
        Neonatal invasive candidiasis: a prospective multicenter study of 118 cases.
        Am J Perinatol. 2003; 20: 153-163
        • Feja K.N.
        • Wu F.
        • Roberts K.
        • Loughrey M.
        • Nesin M.
        • Larson E.
        • et al.
        Risk factors for candidemia in critically ill infants: a matched case-control study.
        J Pediatr. 2005; 147: 156-161
        • Hua S.
        • Huang J.
        • Wu Z.
        • Feng Z.
        A comparison study between Candida parapsilosis sepsis and Candida albicans sepsis in preterm infants.
        Turk J Pediatr. 2012; 54: 502-508
        • Weems Jr., J.J.
        Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility.
        Clin Infect Dis. 1992; 14: 756-766
        • Trofa D.
        • Gácser A.
        • Nosanchuk J.D.
        Candida parapsilosis, an emerging fungal pathogen.
        Clin Microbiol Rev. 2008; 21: 606-625
        • Long S.S.
        • Stevenson D.K.
        Reducing Candida infections during neonatal intensive care: management choices, infection control, and fluconazole prophylaxis.
        J Pediatr. 2005; 147: 135-141
        • Boyce J.M.
        • Pittet D.
        • Healthcare Infection Control Practices Advisory Committee
        Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America, Association for Professionals in Infection Control, Infectious Diseases Society of America.
        MMWR Recomm Rep. 2002; 51: S3-S40
        • Won S.P.
        • Chou H.C.
        • Hsieh W.S.
        • Chen C.Y.
        • Huang S.M.
        • Tsou K.I.
        • et al.
        Handwashing program for the prevention of nosocomial infections in a neonatal intensive care unit.
        Infect Control Hosp Epidemiol. 2004; 25: 742-746
        • Cook H.A.
        • Cimiotti J.P.
        • Della-Latta P.
        • Saiman L.
        • Larson E.L.
        Antimicrobial resistance patterns of colonizing flora on nurses' hands in the neonatal intensive care unit.
        Am J Infect Control. 2007; 35: 231-236
        • Rosenthal M.
        • Aiello A.
        • Larson E.
        • Chenoweth C.
        • Foxman B.
        Healthcare workers' hand microbiome may mediate carriage of hospital pathogens.
        Pathogens. 2013; 3: 1-13
        • Chitnis A.S.
        • Magill S.S.
        • Edwards J.R.
        • Chiller T.M.
        • Fridkin S.K.
        • Lessa F.C.
        Trends in Candida central line-associated bloodstream infections among NICUs, 1999-2009.
        Pediatrics. 2012; 130: e46-e52